STVN NYSE Week ended 24 Jul 2026

Weekly Investor Report

Stevanato Group SpA · Healthcare · Medical Instruments & Supplies

Open interactive chart View report data Download investor PDF
Latest close 19.68 USD
2.7% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 15.2% above the Trend Line and sits at 45.4% of its 52-week range. The latest completed week returned 2.7%, after a 10.3% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is expensive relative to peers. Options positioning is bearish with 36/100 conviction, while the latest news-sentiment score is 54/100. Near-term considerations: volume confirmation is below normal; earnings are due in 5d.

Setup score 43 out of 100
Latest Close 19.68 USD 24 Jul 2026
1W Return 2.7% latest completed week
4W Return 10.3% short-term follow-through
12W Return 11.5% quarterly tape
Trend Breadth 32.7% 17 of 52 weeks active
Volume Ratio 0.8x vs 13-week average
What is working
  • The trend backdrop is active with a 2-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 2.7% Latest completed week; four-week move 10.3%. Indicator stack 25/74 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Bearish 36/100 conviction; expected move 9.1%. News sentiment 54/100 45 relevant articles in the latest sentiment read. Event risk 5d Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 15.2% above the Trend Line and sits at 45.4% of its 52-week range. The latest completed week returned 2.7%, after a 10.3% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.8x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.4512-week average 0.22

12-week confirmation

Trend active2/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.45Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 10.3% over four weeks, 11.5% over 12 weeks, and -25.5% over one year. The current trend has remained active for 2 consecutive weeks.

Performance by holding period

1W2.7%
4W10.3%
12W11.5%
26W14.4%
52W-25.5%
Active trend streak2 weeks
Active weeks in one year17
Trend breadth32.7%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.02Latest activity-pressure read.
Pressure change65.7%Four-week change in activity pressure.
Leadership-8.73Latest relative-leadership reading.
RS change54.6%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 100% Model confidence 96%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength5/100Blend of value, momentum, and quality. Underlying universe rank 96; rank 1 is best.
Value13/100Relative valuation strength. Underlying universe rank 88; rank 1 is best.
Quality35/100Profitability and accounting quality. Underlying universe rank 66; rank 1 is best.
Momentum13/100Medium-term price momentum. Underlying universe rank 88; rank 1 is best.
Growth36/100Revenue and earnings growth. Underlying universe rank 65; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework17/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
38.1x
Price divided by trailing earnings.
Price / sales
4.5x
Market value relative to trailing revenue.
EV / EBITDA
19.4x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
9.2%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
29.0%
Gross profit retained from each unit of revenue.
Operating margin
16.8%
Operating profit retained from revenue.
Free-cash-flow margin
43.9%
Free cash flow generated from revenue.
Return on invested capital
7.9%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
6.7%
Latest one-year revenue growth.
EPS growth
12.3%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-27.7%
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
0.3%
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.3%
Dividend yield plus net buyback yield.
Net debt / EBITDA
1.1x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBearish

STVN shows bearish options pressure with a 36/100 conviction score, put-call volume ratio of 2.00, expected move of 9.1%, and Sharemaestro trend signal active.

Conviction36/100
Expected move9.1%
Put/call volume2.00
Pressure-23
Speculation0
Volatility62
Trend agreement77
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment54/100

Weighted news tone is neutral across 45 relevant articles.

13 positive · 31 neutral · 1 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings5dNext report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
Options expected move9.1%Nearest-chain priced movement where available.
52-week drawdown-29.5%Distance below the 52-week high.
13-week volatility4.0%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2612 weeks finished lower.
Best week+14.9%Week of 17 Apr.
Worst week-9.8%Week of 30 Jan.
Latest week+2.7%Week of 24 Jul.

Shape of recent returns

Strong gains4
Modest gains10
Flat weeks0
Modest losses9
Sharp losses3
Recent vol4.0%13-week weekly-return volatility.
Base vol5.2%52-week weekly-return volatility.
Up/down split25/26Count of positive and negative weeks in the 52-week window.
Average skew3.8% / -4.5%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape38/100

Trend, activity pressure, participation, and risk combine to a 38/100 tape read.

 Indicator analysis42/100

Latest 12-week confirmation: trend 2/12, activity pressure 12/12, relative leadership 0/12.

Activity pressure 0.45; No reversal markers Factors15/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 67; Small Cap Core rank 93 SVQF17/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 838.0 of 1013 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options54/100

STVN shows bearish options pressure with a 36/100 conviction score, put-call volume ratio of 2.00, expected move of 9.1%, and Sharemaestro trend signal active.

Bearish · Put-side pressure · Expected move 9.1% Sentiment54/100

Weighted news tone is neutral across 45 relevant articles.

STVN|Stevanato Group SpA|Price:19.680|Chg%:+0.380 Insiders50/100

No recent insider transaction evidence is stored.

 Earnings5d

Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 202619.68 USD2.7%17.08 USD22.78 USD1.02-8.731.4MOn
17 Jul 202619.17 USD-2.1%17.11 USD22.85 USD0.86-12.501.2MOn
10 Jul 202619.59 USD3.1%17.15 USD22.94 USD0.73-12.771.7MOff
3 Jul 202619.00 USD6.5%17.19 USD23.01 USD0.64-15.051.1MOff
26 Jun 202617.84 USD1.7%17.29 USD23.09 USD0.62-19.241.7MOff
19 Jun 202617.54 USD2.7%17.47 USD23.18 USD0.64-23.261.8MOff
12 Jun 202617.08 USD-7.1%17.63 USD23.28 USD0.67-25.332.6MOff
5 Jun 202618.39 USD-1.1%17.79 USD23.37 USD0.68-19.961.4MOff
29 May 202618.59 USD3.6%17.98 USD23.44 USD0.76-21.84861.2KOff
22 May 202617.95 USD0.1%18.20 USD23.50 USD0.81-24.081.4MOff
15 May 202617.93 USD-1.3%18.47 USD23.55 USD0.75-24.172.2MOff
8 May 202618.16 USD2.9%18.68 USD23.61 USD0.61-23.753.2MOff
1 May 202617.65 USD9.5%18.87 USD23.67 USD-0.02-24.993.3MOff
24 Apr 202616.12 USD4.2%19.14 USD23.73 USD-0.64-31.372.4MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.